Literature DB >> 6260812

Herpesvirus saimiri-induced malignant lymphoma in inbred strain III/J rabbits (Oryctolagus cuniculus).

D V Ablashi, K S Sundar, G Armstrong, P Golway, M Valerio, Z Bengali, J Lemp, R R Fox.   

Abstract

Four young strain III/J rabbits of both sexes were inoculated with a single dose of prototype partially purified Herpesvirus saimiri (HVS) via IV and IM routes. All inoculated animals had enlarged lymph nodes, and significant levels of antibodies to HVS early, late, and membrane antigens were detectable during the infection. The animals died or were killed and HVS was isolated from the peripheral blood mononuclear cells and the various lymph nodes but not from the kidney. Microscopic examination showed that these animals had poorly differentiated lymphomas. The response of mononuclear cells to PHA from peripheral blood of infected animals showed depressed cell mediated immune responses. Humoral and cellular immunity responses during tumorigenesis were comparable to those reported in nonhuman primates with HVS-induced tumors. Thus, the inbred strain III/J appears to be an inexpensive suitable model for studies of oncogenic herpesvirus-induced cancers.

Entities:  

Mesh:

Year:  1980        PMID: 6260812     DOI: 10.1007/bf00405960

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

1.  Clinicopathologic characterization of Herpesvirus saimiri malignant lymphoma in New Zealand white rabbits.

Authors:  R D Hunt; M D Daniel; R B Baggs; B J Blake; D Silva; D DuBose; L V Meléndez
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

2.  Depression in lymphocyte response to general mitogens by owl monkeys infected with Herpesvirus saimiri.

Authors:  W C Wallen; H Rabin; R H Neubauer; J L Cicmanec
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

3.  Induction of herpesvirus saimiri lymphoma in New Zealand white rabbits inoculated intravenously.

Authors:  M D Daniel; R D Hunt; D Dubose; D Silva; L V Melendez
Journal:  IARC Sci Publ       Date:  1975

4.  Antibody patterns to Herpesvirus saimiri-induced antigens in owl monkeys.

Authors:  G R Pearson; T Orr; H Rabin; J Cicmanec; D Ablashi; G Armstrong
Journal:  J Natl Cancer Inst       Date:  1973-12       Impact factor: 13.506

5.  Malignant lymphoma with lymphocytic leukemia induced in owl monkeys by Herpesvirus saimiri.

Authors:  D V Ablashi; W F Loeb; M G Valerio; R H Adamson; G R Armstrong; D G Bennett; U Heine
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

6.  Intracellular and membrane immunofluorescence investigations on cells infected with Herpesvirus saimiri.

Authors:  G Pearson; D Ablashi; T Orr; H Rabin; G Armstrong
Journal:  J Natl Cancer Inst       Date:  1972-11       Impact factor: 13.506

7.  Herpesvirus saimiri: VII. Induction of malignant lymphoma in New Zealand white rabbits.

Authors:  M D Daniel; L V Meléndez; R D Hunt; N W King; M Anver; C E Fraser; H Barahona; R B Baggs
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

8.  Evidence for suppressor cell activity associated with induction of Herpesvirus saimiri-induced lymphoma.

Authors:  W C Wallen; R H Neubauer; H Rabin
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

9.  Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys.

Authors:  G Klein; G Pearson; A Rabson; D V Ablashi; L Falk; L Wolfe; F Dienhardt; H Rabin
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

10.  Herpesvirus saimiri-induced malignant lymphoma in rabbits.

Authors:  S R Rangan; L N Martin; F M Enright; W P Allen
Journal:  J Natl Cancer Inst       Date:  1976-07       Impact factor: 13.506

View more
  1 in total

1.  Herpesvirus saimiri-induced lymphoblastoid rabbit cell line: growth characteristics, virus persistence, and oncogenic properties.

Authors:  D V Ablashi; S Schirm; B Fleckenstein; A Faggioni; J Dahlberg; H Rabin; W Loeb; G Armstrong; J W Peng; G Aulahk
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.